ColE1 Plasmid Antibiotic-Free Selection via RNA I Regulation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The use of antibiotic resistance genes in plasmids for gene therapy is associated with risks such as potential incorporation into mammalian genomes and contamination with residual antibiotics, necessitating the development of antibiotic-free selection methods.

Innovation Solution

A host-vector system utilizing the RNA-based copy number control mechanism of ColE1-type plasmids, where a bacterial host cell contains a DNA sequence encoding a protein and an RNA sequence mimicking RNA II, allowing for selective replication of plasmids without antibiotics by regulating the expression of a marker gene through RNA I-mediated down-regulation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If antibiotic resistance genes are included in plasmids for selection, then plasmid maintenance and selection efficiency are improved, but safety risks increase due to potential incorporation into mammalian genomes and antibiotic contamination

Engineering Contradiction:
Improveplasmid maintenanceVSAvoidsafety risks
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The invention extracts and removes the antibiotic resistance gene from the plasmid structure, retaining only the essential ColE1 origin of replication and marker gene. This extraction eliminates the harmful antibiotic resistance function while preserving plasmid maintenance capability through the RNA I/RNA II copy number control mechanism.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention converts the naturally occurring RNA I/RNA II interaction mechanism, which normally controls plasmid copy number, into a beneficial selection system. By placing a marker gene under control of RNA II and using RNA I to down-regulate it, the system creates antibiotic-free selection where plasmid presence automatically regulates marker expression, turning a replication control mechanism into a selection advantage.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

2Object-affected harmful factors

If antibiotic-free selection methods are used to eliminate safety risks, then safety is improved, but selection efficiency and plasmid maintenance may deteriorate

Engineering Contradiction:
Improvesafety risksVSAvoidplasmid maintenance
Core Design Contradiction:
Object-affected harmful factorsVSReliability

Solution Approach 1:

The invention implements a feedback mechanism where the plasmid's own RNA I transcript automatically regulates marker gene expression through RNA-RNA interaction. When plasmid copy number increases, more RNA I is produced, which down-regulates the marker gene via RNA II, creating a self-regulating system that maintains plasmid stability without antibiotics.

Inventive Principle:
Principle #23Feedback

Solution Approach 2:

The plasmid uses its inherent RNA I transcription mechanism to provide its own selection advantage. The ColE1 origin's natural RNA I/RNA II interaction, which normally serves replication control, is repurposed to automatically regulate marker gene expression, allowing the plasmid to maintain itself through its own molecular machinery without external antibiotic selection.

Inventive Principle:
Principle #25Self-service

3Object-affected harmful factors

If additional genes are added to plasmids for antibiotic-free selection (e.g., host auxotrophy compensation), then selection without antibiotics is achieved, but plasmid complexity increases

Engineering Contradiction:
Improveantibiotic contaminationVSAvoidplasmid structure
Core Design Contradiction:
Object-affected harmful factorsVSDevice complexity

Solution Approach 1:

The invention makes the ColE1 origin's RNA I/RNA II mechanism serve dual functions: its natural role in replication control and a new role in marker gene regulation for selection. This multi-functionality eliminates the need for separate selection gene systems, maintaining plasmid simplicity while achieving antibiotic-free selection.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The invention uses the existing RNA I sequence from the ColE1 origin as a regulatory element for the marker gene, copying the RNA-RNA interaction mechanism rather than creating a entirely new selection system. This approach leverages the proven stability of the ColE1 system while adding selection capability through molecular copying of the regulatory mechanism.

Inventive Principle:
Principle #26Copying

4Reliability

If repressor titration concept is used for antibiotic-free selection, then selection capability is improved, but antibiotic use becomes indispensable

Engineering Contradiction:
Improveselection capabilityVSAvoidantibiotic dependence
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The invention inverts the repressor titration concept by using RNA I (the natural repressor of ColE1 replication) to down-regulate the marker gene instead of using a separate repressor protein. This inversion eliminates the need for antibiotics by using the plasmid's own regulatory RNA to control marker expression, achieving selection through molecular titration without antibiotic dependence.

Inventive Principle:
Principle #13The other way round (Inversion)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This system enables antibiotic-free selection of plasmids, reducing the risk of genetic incorporation and contamination, and allows for efficient plasmid replication, with plasmid-bearing cells surviving toxicity while plasmid-free cells are inhibited, achieving a 99% population increase in less than 10 generations.

Implementation Method 1

the RNA I molecule transcribed from the plasmid hybridizes with said RNA sequence defined in ii), whereby expression of said protein is suppressed

Methodology Applied
Scientific EffectRNA hybridization:

Data Source

PatentUS9297014B2Host-vector system antibiotic-free ColE1 plasmid propagation
Publication Date: 2016.03.29 BOEHRINGER INGELHEIM RCV GMBH & CO KG
  • US9297014B2 patent drawing
  • US9297014B2 patent drawing
  • US9297014B2 patent drawing

AI summary

A host-vector system that uses the RNA-based copy number control mechanism of ColE1-type plasmids for regulating the expression of a marker gene allows for antibiotic-free selection of plasmids and is useful for production of plasmid DNA and recombinant proteins.